Document ID: chunk:federal_register_of_legislation:F2025C00126:schedule:1:p13
Version: federal_register_of_legislation:F2025C00126
Segment Type: schedule
Provision Reference: sch 1 (pt 13/23)
Character Range: 86037–92127

both the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 20 mg, Oral and the brand Zypine ODT of the pharmaceutical item Olanzapine, Tablet 20 mg (orally disintegrating), Oral, added together
Olanzapine                                                                          Tablet 5 mg                                                                                                            Oral                        APO-OLANZAPINE                                      4 months stock by reference to usual demand of both Olanzapine APOTEX and APO-OLANZAPINE added together
Olanzapine                                                                          Tablet 5 mg (orally disintegrating)                                                                                    Oral                        APO‑Olanzapine ODT                                  3 months stock by reference to usual demand
Olanzapine                                                                          Tablet 5 mg (orally disintegrating)                                                                                    Oral                        Zypine ODT                                          (a) between 1 February 2024 and 30 September 2024—4 months stock by reference to usual demand of the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 5 mg, Oral;
                                                                                                                                                                                                                                                                                           (b) between 1 October 2024 and 31 March 2025—4 months stock by reference to usual demand of both the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 5 mg, Oral and the brand Zypine ODT of the pharmaceutical item Olanzapine, Tablet 5 mg (orally disintegrating), Oral, added together
Olanzapine                                                                          Tablet 7.5 mg                                                                                                          Oral                        APO-OLANZAPINE                                      4 months stock by reference to usual demand of both Olanzapine APOTEX and APO-OLANZAPINE added together
Olmesartan                                                                          Tablet containing olmesartan medoxomil 20 mg                                                                           Oral                        OLMERTAN                                            3 months stock by reference to usual demand
Olmesartan                                                                          Tablet containing olmesartan medoxomil 40 mg                                                                           Oral                        OLMERTAN                                            (a) between 1 July 2023 and 31 December 2023—3 months stock by reference to usual demand
                                                                                                                                                                                                                                                                                           (b) after 31 December 2023—3.5 months stock by reference to usual demand
Olmesartan with amlodipine                                                          Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)                                        Oral                        APO-OLMESARTAN/AMLODIPINE 20/5                      4 months stock by reference to usual demand of both Olmesartan/Amlodipine 20/5 APOTEX and APO-OLMESARTAN/AMLODIPINE 20/5 mg added together
Olmesartan with amlodipine                                                          Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate)                                       Oral                        APO-OLMESARTAN/AMLODIPINE 40/10                     4 months stock by reference to usual demand of both Olmesartan/Amlodipine 40/10 APOTEX and APO-OLMESARTAN/AMLODIPINE 40/10 added together
Olmesartan with amlodipine                                                          Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate)                                        Oral                        APO-OLMESARTAN/AMLODIPINE 40/5                      4 months stock by reference to usual demand of both Olmesartan/Amlodipine 40/5 APOTEX and APO-OLMESARTAN/AMLODIPINE 40/5 mg added together
Olmesartan with hydrochlorothiazide                                                 Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg                                          Oral                        OLMERTAN COMBI 20/12.5                              3 months stock by reference to usual demand
Olmesartan with hydrochlorothiazide                                                 Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg                                          Oral                        OLMERTAN COMBI 40/12.5                              3 months stock by reference to usual demand
Olmesartan with hydrochlorothiazide                                                 Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg                                            Oral                        OLMERTAN COMBI 40/25                                3 months stock by reference to usual demand
Ondansetron                                                                         Syrup 4 mg (as hydrochloride dihydrate) per 5 mL, 50 mL                                                                Oral                        Zofran syrup 50 mL                                  4 months stock by reference to usual PBS demand
Ondansetron                                                                         Tablet (orally disintegrating)